Resveratrol Protection Against IL-1β-induced Chondrocyte Damage Via the SIRT1/FOXO1 Signaling Pathway
Overview
Affiliations
Purpose: Osteoarthritis (OA) is a common joint disease characterized by cartilage degeneration, synovial inflammation, osteophytes, and subchondral osteosclerosis. This study investigated the effects of resveratrol (RES) on extracellular matrix (ECM), autophagy, and apoptosis in OA pathogenesis via the SIRT1/FOXO1 pathway.
Methods: The microenvironment of OA chondrocytes was stimulated in vitro by adding 10 ng/mL of IL-1β to primary Wistar rat chondrocyte. Western blotting, immunofluorescence, quantitative real-time PCR, and transmission electron microscopy (TEM) were used for analysis.
Results: In the presence of IL-1β, RES increased the expression of silent information regulator (SIR) 1 protein and the phosphorylation level of forkhead transcription factor (FOXO) 1. It also promoted chondrocyte autophagy, increased the expression of SOX9 and aggrecan, inhibited chondrocyte apoptosis and matrix breakdown, and protected chondrocytes from IL-1β damage. After a SIRT1 inhibitor or FOXO1 inhibitor was added, the protective effect of RES on chondrocytes was significantly weakened. Our results suggest that RES regulates the ECM metabolism, autophagy, and apoptosis of OA chondrocytes through the SIRT1/FOXO1 pathway to ameliorate IL-1β-induced chondrocyte injury.
Conclusion: RES protects chondrocytes from IL-1β-induced damage by activating SIRT1/FOXO1 signaling and holds potential in OA treatment.
Nutritional Epigenomics: Bioactive Dietary Compounds in the Epigenetic Regulation of Osteoarthritis.
Villagran-Andrade K, Nunez-Carro C, Blanco F, de Andres M Pharmaceuticals (Basel). 2024; 17(9).
PMID: 39338311 PMC: 11434976. DOI: 10.3390/ph17091148.
Tang L, Ding J, Yang K, Zong Z, Wu R, Li H J Mol Med (Berl). 2024; 102(10):1229-1244.
PMID: 39145815 DOI: 10.1007/s00109-024-02473-1.
Zhao W, Zhu Y, Wong S, Muhammad N, Pang K, Chin K Heliyon. 2024; 10(13):e34064.
PMID: 39055794 PMC: 11269911. DOI: 10.1016/j.heliyon.2024.e34064.
Zhou Q, Liu J, Wan L, Zhu Y, Qi Y, Hu Y Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(1):108-118.
PMID: 38293982 PMC: 10878885. DOI: 10.12122/j.issn.1673-4254.2024.01.13.
Resveratrol as sensitizer in colorectal cancer plasticity.
Brockmueller A, Sajeev A, Koklesova L, Samuel S, Kubatka P, Busselberg D Cancer Metastasis Rev. 2023; 43(1):55-85.
PMID: 37507626 PMC: 11016130. DOI: 10.1007/s10555-023-10126-x.